Mylan Races To Launch Generic Norvasc
With no time wasted, Mylan launched three strengths of its amlodipine besylate tablets Friday and triggered its 180-day exclusivity.
The pharmaceutical company was the first generic drug maker to file an application for a cheap version of Pfizer’s popular blood pressure drug.
Although it lost its patent challenge against Pfizer some months ago, a second attempt to challenge the patent...
To view the full article, register now.